Sponsor Pipeline

BlueRock Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06944522 A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have… Parkinsons Disease (PD) Recruiting
Phase 1/2
NCT06789445 A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor… Primary Photoreceptor Disease Recruiting
Not specified
NCT05897957 Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01 Parkinson Disease Enrolling by Invitation
NCT05363046 Noninterventional Study Evaluating Parkinson's Disease Diary Use Parkinson's Disease Active, Not Recruiting
Disease Areas
Get alerts when BlueRock Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free